HCG Hospitals - Public Comps and Valuation Multiples

HCG Hospitals Overview

About HCG Hospitals

HealthCare Global Enterprises Ltd operates in oncology, providing comprehensive cancer diagnosis and treatment services including medical oncology, radiation therapy, and surgical oncology. It also offers fertility treatment services under the Milann brand, along with multi-specialty hospital care in key medical disciplines. The company’s operations span many metropolitan and non-metro cities across India and extend internationally with cancer care centers in Africa. HCG generates revenue through patient services in oncology, fertility treatments, diagnostics, and multi-specialty hospital care, leveraging technology and a networked business model to deliver patient-centric healthcare.

Founded

1998

HQ

Employees

5.8K+

Website

hcgoncology.com

Sectors

Hospitals & Clinics

Financials

LTM Revenue $270M

LTM EBITDA $50.0M

EV

$1.1B

Valuation Multiples

Multiples.vc

Valuation Multiples for 15K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Browse Valuation Multiples

HCG Hospitals Financials

As of February 2026, HCG Hospitals reported last 12-month revenue of $270M and EBITDA of $50.0M.

In the same period, HCG Hospitals generated $199M in LTM gross profit and $6.8M in net income.

See HCG Hospitals valuation multiples based on analyst estimates

HCG Hospitals P&L

In the most recent fiscal year, HCG Hospitals reported revenue of $240M and EBITDA of $45.3M.

HCG Hospitals expects next 12-month revenue of XXX and NTM EBITDA of XXX

See HCG Hospitals valuation multiples based on analyst estimates

	LTM	NTM	Last FY	FY 2026	FY 2027	FY 2028
Revenue	$270M	XXX	$240M	XXX	XXX	XXX
Gross Profit	$199M	XXX	$122M	XXX	XXX	XXX
Gross Margin	74%	XXX	51%	XXX	XXX	XXX
EBITDA	$50.0M	XXX	$45.3M	XXX	XXX	XXX
EBITDA Margin	18%	XXX	19%	XXX	XXX	XXX
EBIT	$24.8M	XXX	$20.4M	XXX	XXX	XXX
EBIT Margin	9%	XXX	8%	XXX	XXX	XXX
Net Profit	$6.8M	XXX	$4.9M	XXX	XXX	XXX
Net Margin	3%	XXX	2%	XXX	XXX	XXX
Net Debt	XXX	XXX	$83.7M	XXX	XXX	XXX

Financial data powered by Morningstar, Inc.

.seo-only-financials-wrapper { position: static; left: auto; width: auto; height: auto; overflow: visible; }

Financial performance metrics for HCG Hospitals including revenue, profitability, and margin analysis across different time periods. The company reported last twelve months revenue of $270M. EBITDA for the last twelve months was $50.0M. In the most recent fiscal year, HCG Hospitals achieved $240M in revenue and $45.3M in EBITDA.
Financial Metric	Last Twelve Months (LTM)	Next Twelve Months (NTM)	Most Recent Fiscal Year	Current Fiscal Year (2026)	Next Fiscal Year (2027)	Two Years Forward (2028)
Total Revenue	$270M	Analyst estimates available to subscribers	$240M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit	$199M	Analyst estimates available to subscribers	$122M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit Margin	73.6% gross margin	Analyst estimates available to subscribers	50.8% gross profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA (Earnings Before Interest, Taxes, Depreciation, Amortization)	$50.0M	Analyst estimates available to subscribers	$45.3M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA Margin	18.5% EBITDA margin	Analyst estimates available to subscribers	18.8% EBITDA margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT (Earnings Before Interest and Taxes)	$24.8M	Analyst estimates available to subscribers	$20.4M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT Margin	9.2% EBIT margin	Analyst estimates available to subscribers	8.5% EBIT margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Income (Net Profit)	$6.8M	Analyst estimates available to subscribers	$4.9M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Profit Margin	2.5% net profit margin	Analyst estimates available to subscribers	2.0% net profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Debt Position	Detailed debt information available to subscribers	Detailed debt information available to subscribers	$83.7M	Detailed debt information available to subscribers	Detailed debt information available to subscribers	Detailed debt information available to subscribers

Financial Performance Summary for HCG Hospitals

This financial data table provides comprehensive performance metrics for HCG Hospitals, a company based in India. The metrics include revenue, profitability measures, and operational efficiency indicators across multiple time periods.

Recent Performance Highlights

HCG Hospitals generated $270M in revenue over the last twelve months.
The company achieved $50.0M in EBITDA over the last twelve months.
Gross profit for the last twelve months was $199M.
Net income over the last twelve months reached $6.8M.

Fiscal Year Performance

In the most recent fiscal year, HCG Hospitals reported $240M in total revenue.
Fiscal year EBITDA was $45.3M.
The company maintained a gross profit margin of 50.8% in the most recent fiscal year.
EBITDA margin for the fiscal year was 18.8%.
Net profit margin reached 2.0% in the most recent fiscal year.

This financial data is sourced from Morningstar, Inc. and represents the most recent available information for HCG Hospitals. Forward-looking estimates and detailed financial projections are available through our premium subscription service.

HCG Hospitals Stock Performance

HCG Hospitals has current market cap of INR 81.0B (or $885M), and EV of INR 96.6B (or $1.1B).

Market Cap Evolution

HCG Hospitals Stock Data

As of March 4, 2026, HCG Hospitals's stock price is INR 575 (or $6).

See HCG Hospitals trading valuation data

EV	Market Cap	Price 1D	Price 1M	Price 3M	Price 12M	EPS
$1.1B	$885M	XXX	XXX	XXX	XXX	$0.07

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Start Free Trial

HCG Hospitals Valuation Multiples

HCG Hospitals's trades at 3.9x EV/Revenue multiple, and 20.8x EV/EBITDA.

See valuation multiples for HCG Hospitals and 15K+ public comps

HCG Hospitals Financial Valuation Multiples

As of March 4, 2026, HCG Hospitals has market cap of $885M and EV of $1.1B.

Equity research analysts estimate HCG Hospitals's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

HCG Hospitals has a P/E ratio of 130.5x.

	LTM	NTM	Last FY	FY 2026	FY 2027	FY 2028
Market cap (current)	$885M	XXX	$885M	XXX	XXX	XXX
EV (current)	$1.1B	XXX	$1.1B	XXX	XXX	XXX
EV/Revenue	3.9x	XXX	3.9x	XXX	XXX	XXX
EV/EBITDA	21.1x	XXX	20.8x	XXX	XXX	XXX
EV/EBIT	42.4x	XXX	42.3x	XXX	XXX	XXX
EV/Gross Profit	5.3x	XXX	n/a	XXX	XXX	XXX
P/E	130.5x	XXX	131.3x	XXX	XXX	XXX
EV/FCF	94.1x	XXX	79.4x	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get HCG Hospitals Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Start Free Trial

HCG Hospitals Margins & Growth Rates

HCG Hospitals's last 12 month revenue growth is 15%

HCG Hospitals's revenue per employee in the last FY averaged $41K, while opex per employee averaged $17K for the same period.

HCG Hospitals's rule of 40 is 34% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

HCG Hospitals's rule of X is 56% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for HCG Hospitals and other 15K+ public comps

HCG Hospitals Operational Valuation Multiples

	LTM	NTM	Last FY	FY 2026	FY 2027	FY 2028
Revenue Growth	15%	XXX	15%	XXX	XXX	XXX
EBITDA Margin	18%	XXX	19%	XXX	XXX	XXX
EBITDA Growth	23%	XXX	19%	XXX	XXX	XXX
Rule of 40	34%	XXX	34%	XXX	XXX	XXX
Bessemer Rule of X	XXX	XXX	56%	XXX	XXX	XXX
Revenue per Employee	XXX	XXX	$41K	XXX	XXX	XXX
Opex per Employee	XXX	XXX	$17K	XXX	XXX	XXX
S&M Expenses to Revenue	XXX	XXX	2%	XXX	XXX	XXX
G&A Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
R&D Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
Opex to Revenue	XXX	XXX	42%	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics

Pharma Analytics

Private Equity

ERP Software

Developer Tools

Consumer SaaS

Streaming Platforms

Explore Valuation Multiples by Industry

Start Free Trial